The Formulary Information Exchange (The F.I.X.) is an online drug information service available to subscribers of The Formulary Monograph Service. In this column, we present samples of recent dialog on The F.I.X. If you would like more information on The Formulary Monograph Service or The F.I.X., please call 800-322-4349.
Get full access to this article
View all access options for this article.
References
1.
MurphyM., MorleyA., EglinR.P.Topical trifluridine for mucocutaneous acyclovir-resistant herpes simplex II in AIDS patient. Lancet.1992; 340(Oct): 1040.
2.
KesslerH.A., HurwitzS., FarthingC.Piolot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). J Acquir Immune Defic Synd Hum Retrvirol.1996; 12(2): 147–52.
3.
OlmedoR., HoffmanR.S.Withdrawal syndromes. Emerg Med Clin North Am.2000; 18(2): 273–88.
4.
SpiesC.D., RommelspacherH.Alcohol withdrawal in the surgical patient: Prevention and treatment. Anesth Analg.1999; 88(4): 946–54.
5.
LejoyeuxM., SolomonJ., AdesJ.Benzodiazepine treatment for alcohol-dependent patients. Alcohol.1998; 33(6): 563–75.
6.
SchafferA., NaranjoC.A.Recommended drug treatment strategies for the alcoholic patient. Drugs.1998; 56(4): 571–85.
7.
Mayo-SmithM.F.Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA.1997; 278(2): 144–51.
